In this article, we will discuss the 10 Best NASDAQ Stocks Under $30 to Buy.

On March 9, Allan Small, Senior Investment Advisor for Allan Small Financial Group at iA Private Wealth, appeared on BNN Bloomberg to discuss the extreme volatility of oil prices and the resulting investment opportunities. While he acknowledged that heightened regional tensions will keep prices elevated, energy stocks may face a pullback once the G7, OPEC, or other entities increase supply. He asserted that while wars cause significant immediate volatility, markets typically regain traction and rise a few months after a resolution or ceasefire.

Small observed that while the Dow Jones Industrial Average has been hit hard and the TSX remains mixed amid higher gold and oil prices, the NASDAQ has shown resilience. Small identified large-cap tech names as being extremely cheap and noted they were undervalued even before the war began. He argued that these companies serve as a hideout for investors because they are less affected by Middle Eastern geopolitical shifts than other sectors. He specifically pointed to the strength in software names, which posted positive gains even as the conflict unfolded. Addressing potential concerns about capital flight, Small dismissed the idea that Middle Eastern investors will pull out of the tech sector. On the contrary, he anticipated that these nations would continue to seek out investments in data centers and AI, which remains a positive catalyst for big-cap tech.

Our Methodology

We used screeners to identify NASDAQ stocks that are trading below $30 per share, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.

Note: All data was sourced on March 17. 

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

10 Best NASDAQ Stocks Under $30 to Buy

10. Cellebrite DI Ltd. (NASDAQ:CLBT)

Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the best NASDAQ stocks under $30 to buy. On March 2, Cellebrite officially closed its acquisition of SCG Canada Inc., which provides handheld digital forensics for unmanned aerial vehicles/UAVs. This move integrates SCG’s ability to access, extract, and visualize data from over 80 common drone models into Cellebrite’s AI-powered investigative platform. By adding these capabilities, Cellebrite extends its reach into one of the fastest-growing data sources within the defense, intelligence, and public safety sectors.

The acquisition addresses the global expansion of drone use and the increasing frequency of malicious activity involving these devices. Drones generate massive amounts of mission-critical information, including flight logs, video files, and cell tower connections. SCG’s portable technology allows for rapid data collection and analysis at the point of discovery, providing essential artifacts that can drive better intelligence outcomes and support life-saving decisions in the field through enhanced AI processing.

Leadership from both companies expressed a shared commitment to advancing digital investigations. Cellebrite DI Ltd. (NASDAQ:CLBT) CEO noted that drone data adds significant value to multi-source analysis, while SCG founder highlighted Cellebrite as the ideal partner for scaling these forensic capabilities.

Cellebrite DI Ltd. (NASDAQ:CLBT) is a technology company that develops software & services for legally sanctioned investigations. The company offers a platform of software solutions for managing digital evidence across investigative lifecycles.

9. ADMA Biologics Inc. (NASDAQ:ADMA)

ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best NASDAQ stocks under $30 to buy. On March 2, ADMA Biologics announced a significant capital return initiative for 2026, targeting a total of ~$200 million in share repurchases. As a primary component of this plan, the company entered into a $125 million ASR (accelerated share repurchase) agreement with JPMorgan Chase Bank. This move is supported by the company’s strong financial standing and sustained free cash flow.

Under the specific terms of the ASR, ADMA Biologics will provide an upfront payment of $125 million to JPMorgan and expects to initially receive ~6.4 million shares on or about March 3. This initial delivery represents ~80% of the anticipated total repurchases based on recent closing prices. The average volume-weighted price will determine the final number of shares during the term of the agreement, which is projected to conclude within the next five months.

This initiative is part of a broader $500 million repurchase program authorized in May 2025, through which the company has already returned ~$160 million to stockholders. Moving forward, ADMA Biologics Inc. (NASDAQ:ADMA) intends to remain opportunistic, potentially using Rule 10b5-1 trading plans or open-market transactions to meet the remainder of its 2026 goals.

ADMA Biologics Inc. (NASDAQ:ADMA) is a biotech company that develops and markets specialty plasma-derived biologics for immune deficiencies and infectious diseases through the ADMA BioManufacturing and Plasma Collection Centers segments.

8. SLM Corporation (NASDAQ:SLM)

SLM Corporation (NASDAQ:SLM) is one of the best NASDAQ stocks under $30 to buy. On March 9, SLM Corporation, or simply Sallie Mae, entered into a $200 million ASR (accelerated share repurchase) agreement with Goldman Sachs & Co. LLC. This move is part of a larger $500 million share repurchase program authorized by the company’s Board of Directors on January 22. By prefunding the $200 million ASR on March 10, the company expects to receive and retire a significant portion of shares shortly after execution, leading to a prompt reduction in the total share count.

The CEO noted that this announcement, combined with prior repurchases this quarter, brings the company’s Q1 commitments to ~$300 million. The initiative was implemented following Q4 earnings and amid recent market dislocation. Management indicated a disciplined approach to capital allocation and expressed an intent to exhaust most or all of the current $500 million authorization over 2026, depending on market conditions and available capital.

The final number of shares repurchased through the ASR will be determined by the volume-weighted average price of the common stock during the agreement’s term, adjusted for a discount. While a large portion of shares will be delivered early, the final settlement may involve the receipt of additional shares or, in specific cases, a cash payment or delivery of shares by the company. The transactions under this specific ASR agreement are projected to be completed before the end of Q2 2026.

SLM Corporation (NASDAQ:SLM) is a financial services company that originates and services private education loans to students. The company was formerly known as New BLC Corporation.

7. Ondas Inc. (NASDAQ:ONDS)

Ondas Inc. (NASDAQ:ONDS) is one of the best NASDAQ stocks under $30 to buy. On March 17, Ondas announced the acquisition of INDO Earth Moving Ltd., a company that specializes in heavy engineering equipment for military and national infrastructure. This acquisition follows INDO’s recent $140 million contract award from a major military customer to provide a fleet of heavy-tracked engineering vehicles along with long-term maintenance and logistics support.

The program is expected to begin generating revenue in Q2 2026, with vehicle deliveries spanning two years and sustainment services continuing for at least four years. This move positions Ondas to act as a prime contractor for large-scale military engineering programs while integrating INDO’s hardware expertise with Ondas’ existing robotics and autonomous technologies.

By combining these assets, Ondas Inc. (NASDAQ:ONDS) aims to evolve traditional engineering vehicles into robotic platforms capable of autonomous navigation and remote operation. This integration is designed to enhance safety and effectiveness in demanding environments such as route clearance, obstacle breaching, and defensive construction. Ondas expects significant synergies between INDO and its current autonomous units, including Roboteam, Apeiro, and 4M Defense.

Ondas Inc. (NASDAQ:ONDS) is a technology company that offers private wireless, drone, and automated data solutions through the Ondas Networks and Ondas Autonomous Systems segments.

6. Caris Life Sciences Inc. (NASDAQ:CAI)

Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best NASDAQ stocks under $30 to buy. On March 16, Caris Life Sciences expanded its Caris AI Insights portfolio with a new AI signature designed to predict early platinum resistance in patients with high-grade serous ovarian cancer/HGSOC. This tool uses the company’s proprietary CodeAI platform to analyze Whole Exome Sequencing/WES, Whole Transcriptome Sequencing/WTS, and clinical data.

The signature aims to provide clinicians with molecular foresight into how long a patient might benefit from standard platinum-based chemotherapy before disease progression. HGSOC is an aggressive cancer often diagnosed at advanced stages, with ~20% to 30% of patients experiencing resistance within 6 months of their first treatment. By generating a risk score and classifying patients as platinum-sensitive or platinum-resistant, this technology helps doctors identify those who may need to transition quickly to alternative therapies.

This is particularly significant following recent FDA approvals for new combination treatments specifically targeting platinum-resistant cases. The ovarian cancer AI signature is currently available upon request via the Caris Molecular Tumor Board Report when using the company’s MI Cancer Seek tissue-based test. This test, which received FDA approval in late 2024, is the first of its kind to offer simultaneous WES and WTS-based molecular profiling.

Caris Life Sciences Inc. (NASDAQ:CAI) is a biotech company that provides molecular profiling services and develops & commercializes healthcare solutions using molecular information and AI/ML algorithms.

Click to continue reading and see the 5 Best NASDAQ Stocks Under $30 to Buy.

Disclosure: None. Follow Insider Monkey on Google News.